<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Molecular Diagnostics on SoloSoft</title><link>https://www.solosoft.dev/tags/molecular-diagnostics/</link><description>Recent content in Molecular Diagnostics on SoloSoft</description><generator>Hugo</generator><language>en-us</language><atom:link href="https://www.solosoft.dev/tags/molecular-diagnostics/index.xml" rel="self" type="application/rss+xml"/><item><title>dPCR Market to Surpass US$14.34 Billion by 2031, Driven by Demand for High-Preci</title><link>https://www.solosoft.dev/trends/2026-05-01-dpcr-market-to-surpass-us1434-billion-by-2031-prop/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.solosoft.dev/trends/2026-05-01-dpcr-market-to-surpass-us1434-billion-by-2031-prop/</guid><description>&lt;h2 id="bluf-bottom-line-up-front"&gt;BLUF (Bottom Line Up Front)&lt;/h2&gt;
&lt;p&gt;The global dPCR (digital PCR) market is rapidly climbing from US$7.52 billion (2024) to US$14.34 billion (2031), with a compound annual growth rate of 9.4%. This is not just a numbers game; it marks the transition of precision genetic analysis from academic research into mainstream clinical practice. Driven by three major forces—cancer liquid biopsy, infectious disease monitoring, and personalized medicine—dPCR is no longer a mere &amp;ldquo;upgrade&amp;rdquo; of traditional PCR but a key technology ushering in a new era of molecular diagnostics. Taiwan&amp;rsquo;s biotechnology industry and semiconductor supply chain must recognize the industrial restructuring opportunities brought by this wave of absolute quantification capability.&lt;/p&gt;</description></item></channel></rss>